Cargando…

BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase [Corrigendum]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489820/ https://www.ncbi.nlm.nih.gov/pubmed/26170717 http://dx.doi.org/10.2147/BCTT.S84920

Ejemplares similares

BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase
por: Larsen, Stig, et al.
Publicado: (2014)

Corrigendum to “Effects of Shenfu Injection in the Treatment of Septic Shock Patients: A Multicenter, Controlled, Randomized, Open-Label Trial”
por: Li, Yi, et al.
Publicado: (2016)

Corrigendum to: A Multicenter, Prospective, Randomized, Placebo-Controlled, Double-Blind Study of a Novel Pain Management Device, AT-02, in Patients with Fibromyalgia
Publicado: (2020)

Corrigendum: A Randomized, Double-Blind, Multicenter, Placebo-Controlled Trial of Qi-Zhi-Wei-Tong Granules on Postprandial Distress Syndrome-Predominant Functional Dyspepsia
Publicado: (2019)

Low-Intensity Continuous Ultrasound for the Symptomatic Treatment of Upper Shoulder and Neck Pain: A Randomized, Double-Blind Placebo-Controlled Clinical Trial [Corrigendum]
Publicado: (2020)

Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum]
Publicado: (2015)

Corrigendum to “Efficacy and Safety of Sipjeondaebo-Tang for Anorexia in Patients with Cancer: A Pilot, Randomized, Double-Blind, Placebo-Controlled Trial”
por: Cheon, Chunhoo, et al.
Publicado: (2018)

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Assessing Efficacy and Safety of a Novel Low-Dose Turmeric Extract Formulation in Healthy Adults with Chronic Knee Pain [Corrigendum]
Publicado: (2023)

Short-Term Efficacy of Calcium Fructoborate on Subjects with Knee Discomfort: a Comparative, Double-Blind, Placebo-Controlled Clinical Study [Corrigendum]
Publicado: (2021)

Corrigendum to ‘Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial’
por: von Rotz, Robin, et al.
Publicado: (2023)

The Subjective and Objective Improvement of Non-Invasive Treatment of Schumann Resonance in Insomnia—A Randomized and Double-Blinded Study [Corrigendum]
Publicado: (2022)

Corrigendum to “Local and Systemic Cardiovascular Effects from Monochromatic Infrared Therapy in Patients with Knee Osteoarthritis: A Double-Blind, Randomized, Placebo-Controlled Study”
por: Hsieh, Ru-Lan, et al.
Publicado: (2017)

Corrigendum to “A Randomized, Double-Blind, Placebo-Controlled Trial: The Efficacy of Multispecies Probiotic Supplementation in Alleviating Symptoms of Irritable Bowel Syndrome Associated with Constipation”
por: Mezzasalma, Valerio, et al.
Publicado: (2019)

Agomelatine as monotherapy for major depression: an outpatient, open-label study [Corrigendum]
Publicado: (2013)

Corrigendum to: Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines
por: Ascher, Benjamin, et al.
Publicado: (2021)

Corrigendum to “Topical Colchicine Gel versus Diclofenac Sodium Gel for the Treatment of Actinic Keratoses: A Randomized, Double-Blind Study”
por: Faghihi, Gita, et al.
Publicado: (2017)

Daily Intake of Kaempferia parviflora Extract Decreases Abdominal Fat in Overweight and Preobese Subjects: A Randomized, Double-Blind, Placebo-Controlled Clinical Study [Corrigendum]
Publicado: (2020)

Corrigendum to “A Novel Curcumin-Galactomannoside Complex Delivery System Improves Hepatic Function Markers in Chronic Alcoholics: A Double-Blinded, randomized, Placebo-Controlled Study”
por: Krishnareddy, Naveen T., et al.
Publicado: (2019)

Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression [Corrigendum]
Publicado: (2013)

Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981]
por: Blum, Vinicius Fontanesi, et al.
Publicado: (2021)

c-MYC expression in T (III/IV) stage oral squamous cell carcinoma (OSCC) patients [Corrigendum]
Publicado: (2019)

Morning and evening efficacy evaluation of rupatadine (10 and 20 mg), compared with cetirizine 10 mg in perennial allergic rhinitis: a randomized, double-blind, placebo-controlled trial [Corrigendum]
Publicado: (2015)

Corrigendum to “Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis.”
por: Fiorentino, Giuseppe, et al.
Publicado: (2022)

Corrigendum to: Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy
por: Bogan, Richard K, et al.
Publicado: (2021)

User assessment of Norditropin NordiFlex®, a new prefilled growth hormone pen: a Phase IV multicenter prospective study [Corrigendum]
Publicado: (2013)

Corrigendum to “Long-Term Effects of Goshajinkigan in Prevention of Diabetic Complications: A Randomized Open-Labeled Clinical Trial”
por: Watanabe, K., et al.
Publicado: (2016)

Corrigendum to “The crest phenotype in domestic chicken is caused by a 195 bp duplication in the intron of HOXC10”
por: Li, Jingyi, et al.
Publicado: (2022)

The Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study [Corrigendum]
Publicado: (2022)

Low-Dose Triple Antihypertensive Combination Therapy in Patients with Hypertension: A Randomized, Double-Blind, Phase II Study [Corrigendum]
Publicado: (2021)

A Multicenter 12-Month Retrospective Evaluation of Canaloplasty and Trabeculotomy in Patients with Open-Angle Glaucoma: The ROMEO 2 Study [Corrigendum]
Publicado: (2022)

Longitudinal trajectory analysis of antipsychotic response in patients with schizophrenia: 6-week, randomised, open-label, multicentre clinical trial – CORRIGENDUM
por: Dai, Minhan, et al.
Publicado: (2021)

Effect of a cod protein hydrolysate on postprandial glucose metabolism in healthy subjects: a double-blind cross-over trial — CORRIGENDUM
por: Dale, Hanna Fjeldheim, et al.
Publicado: (2019)

Corrigendum to: 11β-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled tria
Publicado: (2020)

A Prospective, Open-Label Study to Evaluate the Impact of VYC-12L Injection on Skin Quality Attributes in Healthy Volunteers [Corrigendum]
Publicado: (2022)

Corrigendum: The effect of azoximer bromide (Polyoxidonium(®)) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study
Publicado: (2021)

Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines [Corrigendum]
Publicado: (2017)

Corrigendum to “Comparison of Purgative Manna Drop and Phototherapy with Phototherapy Treatment of Neonatal Jaundice: A Randomized Double-Blind Clinical Trial” [Osong Public Health Res Perspect 2019;10(3):152–7]
por: Monsef, Amirreza, et al.
Publicado: (2020)

On Carlsbad Treatment for Anglo-Indians: Corrigendum
Publicado: (1891)

A randomized controlled trial of effects of open-label placebo compared to double-blind placebo and treatment-as-usual on symptoms of allergic rhinitis
por: Schaefer, Michael, et al.
Publicado: (2023)

Corrigendum to “IQP-VV-102, a Novel Proprietary Composition for Weight Reduction: A Double-Blind Randomized Clinical Trial for Evaluation of Efficacy and Safety”
por: Grube, Barbara, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_egmcmoa0vufgi55ntpuv978hcs